E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/9/2006 in the Prospect News Biotech Daily.

RBC keeps Connetics at sector perform

Connetics Corp. was maintained by RBC Capital Markets analyst Ken Trbovich at its sector perform, speculative risk rating and $17 price target. The company "significantly missed" the analyst's third-quarter total revenue and loss per share expectations due to inventory reductions. Total revenue was $19.7 million compared to RBC's estimate of $28.4 million. Adjusted loss per share was $0.65, compared to the analyst's expected loss per share of $0.52. Connetics said it will continue to write work down channel inventory from the current level of approximately 6 to 7 weeks, to 4 to 6 weeks. Shares of the Palo Alto, Calif.-based specialty pharmaceutical company were down 14 cents, or 0.82%, at $16.91. (Nasdaq: CNCT)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.